1-5 of 5
Jessica M McCarty
Close
Sort by
Journal Articles

Phase II Trial of Venetoclax (Ven) in Combination with Azacitidine (AZA) As Maintenance Therapy for High-Risk Acute Leukemia Following Allogeneic Stem Cell Transplantation (SCT)

Betul Oran, Richard E Champlin, Peter F Thall, Jessica M McCarty, Wen Zhang, David Marin, Rohtesh S. Mehta, Amin M Alousi, Gheath Alatrash, Uday R Popat, Hagop Kantarjian, Qaiser Bashir, Elizabeth J Shpall, Marina Konopleva
Journal: Blood
Blood (2022) 140 (Supplement 1): 10561–10562.
https://doi.org/10.1182/blood-2022-159312
Published: 2022
Journal Articles

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Richard E Champlin, Esther Bachar Lustig, Qaiser Bashir, Betul Oran, Steven M. Kornblau, Chitra Hosing, Amin M Alousi, Uday R Popat, Jessica M McCarty, Peter F Thall, Bouthaina S. Dabaja, Wei-Hsin Liu, Giang Dang, Karla Castro, Alejandro Ramirez, Michael Spiotto, Susan Wu, Penny Fang, Indreshpal Kaur, Katy Rezvani, Elizabeth J Shpall, Yair Reisner
Journal: Blood
Blood (2022) 140 (Supplement 1): 2120–2122.
https://doi.org/10.1182/blood-2022-159183
Published: 2022
Journal Articles

Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation

Betul Oran, MDMS, Gheath Alatrash, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Chitra Hosing, MD, Uday R. Popat, MD, Jin S. Im, Jessica M McCarty, RN, Jennifer D Ramos, RN, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-134272
Published: 2020
Journal Articles

Minimal Residual Disease Eradication with Guadecitabine (SGI-110) in the Post-Transplant Setting

Betul Oran, MDMS, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, David Marin, Partow Kebriaei, MD, Uday R. Popat, MD, Amanda L. Olson, Jessica M McCarty, RN, Jennifer D Ramos, RN, Roland Bassett, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-134204
Published: 2020
Journal Articles

Safety Analysis of Intra-Patient Dose- Study of Crenolanib Maintenance Therapy in Patients with FLT3 Mutant AML Following Allogeneic Hematopoietic Stem Cell Transplant

Betul Oran, MDMS, Stefan O. Ciurea, David Marin, MD, Jessica M McCarty, Qaiser Bashir, MD MBBS, Sairah Ahmed, MD, Amanda L. Olson, MD, Uday Popat, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Trishala Agrawal, MD, Richard E Champlin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3426.
https://doi.org/10.1182/blood-2018-99-119390
Published: 2018